Harvard Bioscience (HBIO) Cash from Restructuring (2010 - 2016)
Harvard Bioscience (HBIO) reported Cash from Restructuring of -$27000.0 for Q3 2016, down 80.0% year-over-year from -$135000.0 in Q4 2015, and down 350.0% quarter-over-quarter from -$6000.0 in Q4 2015.
Harvard Bioscience (HBIO) Cash from Restructuring (2010 - 2016) Analysis & Trends
Harvard Bioscience (HBIO) has 6 years of Cash from Restructuring data on file, last reported at -$27000.0 in Q3 2016.
- Cash from Restructuring for Q3 2016 came in at -$27000.0, down 80.0% year-over-year; the trailing twelve-month figure through Dec 2017 was -$27000.0 (changed 0.0% YoY), and the FY2016 annual result was -$27000.0, up 68.24% from the prior year.
- Cash from Restructuring fell to -$27000.0 in Q3 2016 per HBIO's latest filing, from -$6000.0 in the prior quarter.
- Over five years, Cash from Restructuring peaked at $95000.0 in Q3 2013 and troughed at -$102000.0 in Q1 2014.
- A 4-year average of -$25272.7 and a median of -$21000.0 in 2013 frame the typical range for Cash from Restructuring.
- The sharpest annual moves came in 2014 and 2015: Cash from Restructuring surged 30.43% in 2014, then plunged 650.0% in 2015.
- A 4-year view of Cash from Restructuring shows it stood at -$97000.0 in 2013, then soared by 97.94% to -$2000.0 in 2014, then sank by 200.0% to -$6000.0 in 2015, then tumbled by 350.0% to -$27000.0 in 2016.
- Business Quant data shows HBIO's Cash from Restructuring at -$27000.0 in Q3 2016, -$6000.0 in Q4 2015, and -$15000.0 in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | -27,000.00 |
| Dec 31, 2015 | -6,000.00 |
| Sep 30, 2015 | -15,000.00 |
| Jun 30, 2015 | -64,000.00 |
| Sep 30, 2014 | -2,000.00 |
| Jun 30, 2014 | -16,000.00 |
| Mar 31, 2014 | -102,000.00 |
| Dec 31, 2013 | -97,000.00 |
| Sep 30, 2013 | 95,000.00 |
| Jun 30, 2013 | -23,000.00 |
| Mar 31, 2013 | -21,000.00 |
| Dec 31, 2011 | -70,000.00 |
| Sep 30, 2011 | 308,000.00 |
| Dec 31, 2010 | 79,000.00 |